AML-SCAPE: Spatial Cellular Architecture and Programming of the Immune Environment in Acute Myeloid Leukemia
Acute myeloid leukemia (AML) is an aggressive type of blood cancer with limited long-term survival despite advances in treatment. In addition to changes within leukemia cells themselves, the surrounding bone marrow microenvironment contributes to AML pathogenesis. This environment, also known as the bone marrow niche, is enriched in interactions between immune cells and leukemia cells that may help AML to survive and persist. However, the underlying mechanisms are poorly understood. Jana Ihlow uses advanced single-cell and spatial technologies to investigate how AML alters the bone marrow microenvironment and how these changes differ before and after chemotherapy. She aims to predict immune mechanisms directed against AML cells and determine how they influence treatment response and disease progression. Ultimately, she seeks to identify new biological markers that infer disease outcome and pave the way towards new personalized therapies for AML.
Further information: https://pathologie-ccm.charite.de/forschung/ag_haematopathologie/